Literature DB >> 2548603

Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases.

R Nicholson1, G Murphy, R Breathnach.   

Abstract

Rat transin and human stromelysin 2 mRNAs, which have been associated with malignant tumors, code for potential proteins with significant sequence homology to the metalloproteinases collagenase and stromelysin. We have used an expression system that allows easy purification of these proteins after transfection of COS cells with a vector containing the corresponding cDNA. This system has allowed us to prepare transin and stromelysin 2 as active proteinases that are inhibited by inhibitors of metalloproteinases. Further analysis of these enzymes indicates that they degrade several components of the extracellular matrix including collagen types III, IV, and V and fibronectin, as well as gelatins formed from several denatured collagen types. In addition, both transin and stromelysin 2 are capable of activating procollagenase in vitro. Thus, in malignant tumors these proteinases may act, both directly and indirectly, to degrade the extracellular matrix and permit tumor invasion of neighboring tissues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548603     DOI: 10.1021/bi00438a042

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

Review 1.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

2.  Immunoelectron microscopy shows an atypical pattern and a quantitative shift of collagens type I, III and VI in oral Kaposi's sarcoma of AIDS.

Authors:  J Becker; D Schuppan; J P Rabanus; H R Gelderblom; P Reichart
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 3.  Matrix metalloproteinases in emphysema.

Authors:  Sina A Gharib; Anne M Manicone; William C Parks
Journal:  Matrix Biol       Date:  2018-03-23       Impact factor: 11.583

4.  Regulation of the transcription factor Ets-1 by DNA-mediated homo-dimerization.

Authors:  Ekaterina P Lamber; Laurent Vanhille; Larissa C Textor; Galina S Kachalova; Michael H Sieweke; Matthias Wilmanns
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

Review 5.  Matrix metalloproteinase inhibitors: present achievements and future prospects.

Authors:  L J Denis; J Verweij
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

6.  Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.

Authors:  Jyotica Batra; Jessica Robinson; Alexei S Soares; Alan P Fields; Derek C Radisky; Evette S Radisky
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

7.  Increased proteinase expression during tumor progression of cell lines down-modulated for TIMP levels: a new transformation paradigm? [corrected].

Authors:  R Khokha; P Waterhouse; P Lala; M Zimmer; D T Denhardt; R Khokka
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 8.  Stromelysin in tumor progression and metastasis.

Authors:  S McDonnell; L M Matrisian
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

9.  Time-resolved analysis of the matrix metalloproteinase 10 substrate degradome.

Authors:  Pascal Schlage; Fabian E Egli; Paolo Nanni; Lauren W Wang; Jayachandran N Kizhakkedathu; Suneel S Apte; Ulrich auf dem Keller
Journal:  Mol Cell Proteomics       Date:  2013-11-26       Impact factor: 5.911

Review 10.  Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.